论文部分内容阅读
Human esophageal cancer(EC)is the eighth most prevalent cancer worldwide and the sixth leading cause of cancer deaths throughout the world.The poor prognosis and the sub-optimal 5-year survival rate of EC deserve further exploration of novel therapeutic agents against this disease.